Camellia sinensis 'Tsuyuhikari'

Camellia sinensis 'Tsuyuhikari' is a Japanese green tea cultivar containing catechins, particularly epigallocatechin gallate (EGCG), along with theanine and chlorophyll-related compounds. No cultivar-specific clinical research exists, so its bioactivity is inferred from general green tea polyphenol pharmacology rather than direct study.

Origin & History

Camellia sinensis 'Tsuyuhikari' is a Japanese tea cultivar developed in 1972 at the Shizuoka Prefectural Tea Research Institute through crossbreeding of Shizu7132 and Asatsuyu strains. This early-harvesting cultivar produces high-quality sencha through traditional processing methods including plucking, steaming, rolling, and drying. It features pale green young leaves, vigorous growth, and enhanced resistance to anthracnose and cold compared to standard tea varieties.

Historical & Cultural Context

Tsuyuhikari, developed in 1972, has no historical traditional medicine use as it postdates classical systems like TCM and Kampo, which have employed wild C. sinensis varieties since approximately 2700 BCE. Modern Japanese tea culture values this cultivar for its superior sencha quality and umami flavor profile rather than medicinal properties.

Health Benefits

• No cultivar-specific health benefits documented - evidence quality: absent
• General green tea benefits may apply but are not studied for this cultivar - evidence quality: theoretical
• Potential antioxidant effects from typical tea polyphenols - evidence quality: assumed, not tested
• May share metabolic benefits of other C. sinensis varieties - evidence quality: extrapolated from general tea research
• Traditional tea benefits for digestion and vitality possible but unverified - evidence quality: traditional use only

How It Works

Like other Camellia sinensis cultivars, Tsuyuhikari likely delivers catechins such as EGCG that inhibit catechol-O-methyltransferase (COMT) and modulate Nrf2-mediated antioxidant gene expression. EGCG can bind directly to the 67-kDa laminin receptor, influencing cell signaling cascades including MAPK and PI3K/Akt pathways. Theanine, also presumed present, modulates GABA and NMDA receptor activity, potentially supporting calm alertness when combined with caffeine.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Tsuyuhikari were identified in available research. While general green tea research exists (such as PMID: 28578048 on weight loss), all available studies on this cultivar focus exclusively on agronomic traits rather than biomedical outcomes.

Clinical Summary

No clinical trials have investigated Camellia sinensis 'Tsuyuhikari' specifically as a supplement or health intervention. Evidence for any benefits is entirely extrapolated from studies on generic green tea or other Japanese cultivars such as Yabukita. Meta-analyses of green tea catechins (e.g., Cochrane reviews encompassing hundreds of trials) show modest reductions in LDL cholesterol and systolic blood pressure, but these findings cannot be reliably attributed to this cultivar without direct testing. The evidence quality for Tsuyuhikari-specific health claims must be rated as absent to theoretical.

Nutritional Profile

Camellia sinensis 'Tsuyuhikari' is a Japanese green tea cultivar developed by the National Agriculture and Food Research Organization (NARO), registered in 1990. As a shaded green tea cultivar with umami characteristics, its nutritional profile follows general gyokuro/kabusecha-style tea biochemistry with the following estimated composition per 100ml brewed tea (based on comparable shaded cultivar data): Catechins: 50-120mg total (lower than sun-grown cultivars due to shading-induced reduction; epigallocatechin gallate [EGCG] estimated 20-60mg, epicatechin gallate [ECG] 5-15mg, epicatechin [EC] 5-10mg, epigallocatechin [EGC] 10-30mg); L-Theanine: 15-40mg per 100ml (elevated relative to unshaded cultivars, as shading suppresses conversion of theanine to catechins, characteristic of umami-forward cultivars); Caffeine: 20-40mg per 100ml; Chlorophyll a and b: combined 1-3mg per gram dry leaf (shading increases chlorophyll synthesis, contributing to deep green color); Vitamin C (ascorbic acid): approximately 3-6mg per 100ml brewed; Vitamin K1 (phylloquinone): approximately 20-60mcg per 100ml; Potassium: 20-30mg per 100ml; Fluoride: 0.1-0.3mg per 100ml; Manganese: 0.2-0.5mg per 100ml; Gallic acid and other phenolic acids: present at trace levels 1-5mg per 100ml. Dry leaf protein content estimated at 20-25% of dry weight, largely insoluble and not bioavailable in brewed form. Theanine bioavailability is high (>80%) in aqueous infusion. Catechin bioavailability is moderate (1-10% systemic absorption) and varies with brewing temperature and steeping time. No cultivar-specific analytical studies have been published; all values are interpolated from shaded Japanese green tea cultivar literature (e.g., Yabukita, Okumidori, Asatsuyu comparisons).

Preparation & Dosage

No clinically studied dosages for Tsuyuhikari exist. General green tea recommendations suggest 200-400 mg catechins daily from extracts, but standardization and specific forms for this cultivar are undocumented. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

L-theanine, EGCG extract, vitamin C, quercetin, green tea extract

Safety & Interactions

Green tea catechins at high supplemental doses (above 800 mg EGCG/day) have been associated with hepatotoxicity in case reports and some clinical studies, so caution is warranted if Tsuyuhikari extracts were consumed in concentrated form. Caffeine content in any Camellia sinensis cultivar may interact with MAO inhibitors, adenosine medications, and stimulant drugs, amplifying cardiovascular effects. Pregnant individuals are advised to limit caffeine intake below 200 mg/day per major obstetric guidelines, which applies to this cultivar as with all tea. Catechins can reduce iron absorption by up to 25% when consumed with meals, a relevant consideration for individuals with iron-deficiency anemia.